Marker Therapeutics, Inc.
MRKR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001094038
No open-market purchases or sales by Marker Therapeutics, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.84M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Marker Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q4 2023
- Shares held
- 1.98M
- +4.55K (+0.2%) vs. Q4 2023
- Total value
- $8.52M
- −$2.35M (−21.6%) vs. Q4 2023
- New holders
- 3
- 8 more added
- Sold out
- 1
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRKR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $5.84M |
| Q1 2026 | 35 | $5.07M |
| Q4 2025 | 36 | $6.03M |
| Q3 2025 | 32 | $3.09M |
| Q2 2025 | 31 | $5.22M |
| Q1 2025 | 32 | $5.04M |
| Q4 2024 | 33 | $11.0M |
| Q3 2024 | 28 | $5.67M |
| Q2 2024 | 28 | $10.9M |
| Q1 2024 | 28 | $8.52M |
| Q4 2023 | 26 | $10.9M |
| Q3 2023 | 28 | $8.82M |
| Q2 2023 | 29 | $5.78M |
| Q1 2023 | 30 | $1.41M |
| Q4 2022 | 48 | $5.21M |
| Q3 2022 | 47 | $7.54M |
| Q2 2022 | 50 | $7.35M |
| Q1 2022 | 52 | $10.3M |
| Q4 2021 | 65 | $25.1M |
| Q3 2021 | 63 | $44.7M |
| Q2 2021 | 74 | $75.8M |
| Q1 2021 | 74 | $56.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Marker Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 1,071,428 | $4.61M | 0.29% | 00.0% | Unchanged |
| Aisling Capital Management LP | 314,286 | $1.35M | 0.46% | 00.0% | Unchanged |
| Vanguard Group Inc | 233,231 | $1.00M | 0.00% | +8,174+3.6% | Added |
| Ar Asset Management Inc | 70,700 | $304.0K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 67,053 | $288.4K | 0.00% | +7,006+11.7% | Added |
| Wedbush Securities Inc | 45,500 | $196.0K | 0.01% | −24,000−34.5% | Reduced |
| Renaissance Technologies LLC | 37,250 | $160.0K | 0.00% | −300−0.8% | Reduced |
| Northern Trust Corp | 34,823 | $149.7K | 0.00% | −3,888−10.0% | Reduced |
| Dimensional Fund Advisors LP | 20,278 | $87.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,748 | $84.9K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 17,312 | $74.4K | 0.00% | 00.0% | Unchanged |
| Matrix Asset Advisors Inc | 15,000 | $64.5K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,817 | $63.7K | 0.00% | +14,817 | New |
| Advisor Group Holdings, Inc. | 8,585 | $36.9K | 0.00% | +2,200+34.5% | Added |
| Morgan Stanley | 4,040 | $17.4K | 0.00% | +442+12.3% | Added |
| Bank of America Corp | 2,562 | $11.0K | 0.00% | +228+9.8% | Added |
| Riggs Asset Managment Co. Inc. | 1,400 | $6.02K | 0.00% | −200−12.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,333 | $5.73K | 0.00% | +21+1.6% | Added |
| BlackRock Inc. | 992 | $4.27K | 0.00% | −372−27.3% | Reduced |
| US Bancorp | 839 | $3.61K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 427 | $1.84K | 0.00% | +427 | New |
| Wells Fargo & Company | 284 | $1.22K | 0.00% | +1+0.4% | Added |
| Group One Trading, L.P. | 178 | $765 | 0.00% | 00.0% | Unchanged |
| Hilltop National Bank | 73 | $314 | 0.00% | +73 | New |
| JPMorgan Chase & Co | 38 | $164 | 0.00% | +5+15.2% | Added |
| Versant Capital Management, Inc | 15 | $65 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 12 | $52 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 15 | $0 | 0.00% | −16−51.6% | Reduced |
| Huntington National Bank | 0 | $0 | 0.00% | −70−100.0% | Sold out |